Pharmaceutical composition comprising a combination of Lamotrigine and clonazepam and its use in the treatment of Seizure Disorders and Epilepsy syndromes

摘要

The present Invention is applied in the pharmaceutical industry, and describes a Pharmaceutical composition comprising a synergistic combination of an anticonvulsant Agent, as is the active principle Agent: Lamotrigine and a Benzodiazepine, as is the active Principle: clonazepa M, which are formulated in a single Dosing UnitIt is indicated for the Control and Treatment of Seizure Disorders and Epilepsy syndromes.The combination of active principles above produces a Greater Synergistic effect when administered together in a single Unit of dose difference when they are administered independently, generating benefits such as: Lower concentrations of the main Active principles formulated, lower doses, faster action,Greater Effectiveness of therapeutic effect and less risk of the onset of adverse effects.